As of February 2020, in terms of credit by value, private sector banks have been the largest contributors to the drugs and pharmaceuticals industry in India, with a share of over 37 percent. This was followed by foreign banks and public sector banks, at roughly 25 and 21 percent respectively.
Financing pattern of drugs and pharmaceutical industry in India as of February 2020, by value
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Import share of pharmaceuticals to Sweden 2023, by country
- Basic Statistic Export share of pharmaceuticals from Sweden 2023, by country
- Basic Statistic Pharmaceutical industry trade balance of Canada 2004-2022
- Premium Statistic Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Basic Statistic Pharmaceutical industry: the cost of introducing a new product 1970-2010s
- Premium Statistic Pharmaceutical imports in Mexico 2022, by country
- Basic Statistic Pharma imports & exports in Latin America 2022, by country
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Basic Statistic Worldwide top origins for pipeline drugs by number of active drugs 2024
- Basic Statistic Gross profit of Sobi 2009-2023
About the region
10
- Premium Statistic Net profit of major pharma companies India 2024
- Premium Statistic Non-performing assets share of DCCBs India FY 2008-2020
- Premium Statistic Non-performing asset share of PACs India FY 2008-2019
- Premium Statistic Non-performing assets share of UCBs in India FY 2008-2020
- Premium Statistic Non-performing asset share of StCBs India FY 2008-2020
- Premium Statistic Non-performing assets share of SCARDBs India FY 2008-2020
- Premium Statistic Non-performing asset share of PCARDBs India FY 2008-2020
- Premium Statistic Value of the nutraceutical market in India 2012-2022
- Premium Statistic Distribution of the functional food and beverage market in India 2018
- Premium Statistic Distribution of the functional food market in India 2018 by product type
Selected statistics
10
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Premium Statistic U.S. branded prescription revenue forecast 2009-2015
Other regions
10
- Basic Statistic UK pharmaceutical products export value to the EU 2018-2022
- Basic Statistic Share of retail Rx by payer oral solid opioids vs. all drugs Canada 2017
- Premium Statistic Share of units sold of Rx oral solid opioids in U.S. 2017 by drug
- Basic Statistic Canadian vs US price difference of select oral solid opioids 2017
- Premium Statistic Global autism spectrum disorder therapeutics market size in 2018 and 2026
- Basic Statistic Antihypertensive pharmaceutical consumption in Luxembourg 2009-2022
- Basic Statistic Share value of the generic pharmaceuticals market in Slovakia 2002-2021
- Basic Statistic Cardiovascular system pharmaceutical consumption in Portugal 2009-2022
- Basic Statistic Share value of the generic pharmaceuticals market in Switzerland 2002-2022
- Basic Statistic Antacids pharmaceutical consumption in Spain 2004-2012
Related statistics
10
- Basic Statistic Medicine and pharmaceutical product import value India FY 1961-2023
- Premium Statistic Lupin's net sales FY 2015-2023
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Value of surgical instruments exported from India FY 2015-2023
- Basic Statistic Medical instrument export value from India FY 2022, by type
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Operating income of the Industrial and Commercial Bank of China 2013-2023
- Total assets of the Industrial and Commercial Bank of China 2012-2023
- Operating income of the Bank of Communications 2013-2023
- Total assets of the Bank of Communications 2013-2023
- Total assets of the China Construction Bank 2013-2023
- Total assets of Banco Santander 2001-2023
- Profit development of Santander group 2001-2023
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Operating income of the Industrial and Commercial Bank of China 2013-2023
- Total assets of the Industrial and Commercial Bank of China 2012-2023
- Operating income of the Bank of Communications 2013-2023
- Total assets of the Bank of Communications 2013-2023
- Total assets of the China Construction Bank 2013-2023
- Total assets of Banco Santander 2001-2023
- Profit development of Santander group 2001-2023
CRIF. (September 18, 2020). Financing pattern of drugs and pharmaceutical industry in India as of February 2020, by value [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1179056/india-financing-pattern-of-drugs-and-pharmaceutical-industry-by-value/
CRIF. "Financing pattern of drugs and pharmaceutical industry in India as of February 2020, by value." Chart. September 18, 2020. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1179056/india-financing-pattern-of-drugs-and-pharmaceutical-industry-by-value/
CRIF. (2020). Financing pattern of drugs and pharmaceutical industry in India as of February 2020, by value. Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1179056/india-financing-pattern-of-drugs-and-pharmaceutical-industry-by-value/
CRIF. "Financing Pattern of Drugs and Pharmaceutical Industry in India as of February 2020, by Value." Statista, Statista Inc., 18 Sep 2020, https://www.statista.com/statistics/1179056/india-financing-pattern-of-drugs-and-pharmaceutical-industry-by-value/
CRIF, Financing pattern of drugs and pharmaceutical industry in India as of February 2020, by value Statista, https://www.statista.com/statistics/1179056/india-financing-pattern-of-drugs-and-pharmaceutical-industry-by-value/ (last visited June 01, 2024)
Financing pattern of drugs and pharmaceutical industry in India as of February 2020, by value [Graph], CRIF, September 18, 2020. [Online]. Available: https://www.statista.com/statistics/1179056/india-financing-pattern-of-drugs-and-pharmaceutical-industry-by-value/